Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial 4B-13-3
An Integrated Phase II/III, Open Label, Randomized, Parallel and Controlled Study of the Safety and Efficacy of CG0070 Oncolytic Vector Regimen In Patients with Non-Muscle Invasive Bladder Carcinoma in Situ Disease (“NMIBCis”, meaning CIS and CIS with TAand/or T1) and who have failed BCG Therapy and Refused Cystectomy
Type:
Treatment
Phase:
Phase II/III
Status:
Not Open (Never Opened)
Treatments:
Randomized:
Not Asked
USC Satellite Location:
None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Siamak Daneshmand, M.D.
Other Trial Staff:
Staff may
log in
to see study documents.
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.